In The News

UGenome AI, a pioneer in genomic platforms to fuel personalized medicine, announced a strategic partnership with Jura Health, Inc. to leverage UGenome technology for rare disease patient diagnosis and personalized plans. This collaboration empowers those with rare genetic disorders to learn about their pharmacogenomic profile faster, shorten diagnosis and treatment timelines, and support disease outcomes.

Innosphere’s Life Sciences Incubator celebrates graduating its first cohort of companies. Operating under a U.S. Economic Development Administration Build to Scale Grant, this impact-oriented program aims to catapult participating organizations’ concepts into market-ready solutions. The majority of selected companies focus on solutions that align with the national priorities set in the 2022 CHIPS and Science Act.

Jura Health has been selected to advance as a Semifinalist in Colorado's 2024 Prime Health Innovation Challenge! Prime Health’s Innovation Challenge is an annual program that advances healthcare through innovation, aiming to improve health equity, access, quality, and cost for underserved communities in California and Colorado.

20-June-2024: Jura Health, an Innosphere Ventures client company, committed to health equity for rare disease patients and their families, is pleased to announce that its offerings are now approved for payment by Medicaid in Colorado. This new coverage will enhance access to crucial health information for anyone suspected of having a rare disease.